Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-13-001863
Filing Date
2013-01-10
Accepted
2013-01-10 16:45:23
Documents
4
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A a13-2592_110qa.htm 10-Q/A 35902
2 EX-10.1 a13-2592_1ex10d1.htm EX-10.1 411940
3 EX-31.1 a13-2592_1ex31d1.htm EX-31.1 5439
4 EX-31.2 a13-2592_1ex31d2.htm EX-31.2 5409
  Complete submission text file 0001104659-13-001863.txt   459829
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-50626 | Film No.: 13523330
SIC: 2834 Pharmaceutical Preparations